Editorial: Tumor Microenvironment in Cancer Hallmarks and Therapeutics

Overview

Journal Front Mol Biosci

Specialty Biology

Date 2022 Sep 29

PMID 36172048

Authors

Na Luo

Affiliations

Soon will be listed here.

Citing Articles

Targeting YAP1 to improve the efficacy of immune checkpoint inhibitors in liver cancer: mechanism and strategy.

Gao Y, Gong Y, Lu J, Hao H, Shi X Front Immunol. 2024; 15:1377722.

PMID: 38550587 PMC: 10972981. DOI: 10.3389/fimmu.2024.1377722.

Systems Biology and Cytokines Potential Role in Lung Cancer Immunotherapy Targeting Autophagic Axis.

Khilwani R, Singh S Biomedicines. 2023; 11(10).

PMID: 37893079 PMC: 10604646. DOI: 10.3390/biomedicines11102706.

Insights on the Role of Polyphenols in Combating Cancer Drug Resistance.

Farhan M Biomedicines. 2023; 11(6).

PMID: 37371804 PMC: 10296548. DOI: 10.3390/biomedicines11061709.

References

Yip H, Papa A . Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments. Cells. 2021; 10(3). PMC: 8002322. DOI: 10.3390/cells10030659. View

Li M, Zha X, Wang S . The role of N6-methyladenosine mRNA in the tumor microenvironment. Biochim Biophys Acta Rev Cancer. 2021; 1875(2):188522. DOI: 10.1016/j.bbcan.2021.188522. View

Di Agostino S, Vahabi M, Turco C, Fontemaggi G . Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative Breast Cancer. Noncoding RNA. 2022; 8(1). PMC: 8788502. DOI: 10.3390/ncrna8010005. View

Feltes B, Poloni J, Nunes I, Faria S, Dorn M . Multi-Approach Bioinformatics Analysis of Curated Omics Data Provides a Gene Expression Panorama for Multiple Cancer Types. Front Genet. 2020; 11:586602. PMC: 7719697. DOI: 10.3389/fgene.2020.586602. View

Jacob J, Jacob M, Parajuli P . Review of immune checkpoint inhibitors in immuno-oncology. Adv Pharmacol. 2021; 91:111-139. DOI: 10.1016/bs.apha.2021.01.002. View